Abbott India peers

Companies like Abbott Indialatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ABBOTINDIA₹26,275.00

Abbott India Ltd.

· Pharma & Health
₹ CrorePeersPFIZERGLAXOIPCALABAJANTPHARMANTHEMMEDANTAGLENMARKBIOCON
Comp Set
In ₹ Crore except Per Share
Latest Annual
ABBOTINDIA
FY26
PFIZER
FY26
GLAXO
FY26
IPCALAB
FY26
Peer
Average
Valuation — at last close
P/E——45.82×◆ 42.92×44.37×
P/B——18.66×◆ 6.07×12.37×
EV/EBITDA——30.21×◆ 25.24×27.73×
Market Cap——₹42,319 Cr₹48,977 Cr₹45,648 Cr
Growth
Revenue CAGR 3Y9.01%1.29%5.53%◆ 15.60%7.47% +21%
Revenue CAGR 5Y9.96%2.39%3.62%◆ 12.22%6.08% +64%
Net Income CAGR 3Y17.80%5.01%19.26%◆ 35.20%19.82% -10%
Revenue YoY (latest Q)——16.55%◆ 20.76%18.66%
Net Income YoY (latest Q)——15.69%◆ 82.18%48.94%
Profitability
EBITDA Margin27.31%◆ 35.88%34.26%20.51%30.22% -10%
Net Income Margin22.40%◆ 28.67%27.11%12.27%22.68% -1%
Return on Common Equity34.46%17.16%◆ 49.11%15.20%27.16% +27%
Return on Capital Employed38.09%19.60%◆ 52.35%16.05%29.33% +30%
Return on Assets◆ 24.99%14.69%24.57%9.81%16.36% +53%
Credit & Quality
Total Debt/Equity—◆ 0.00×0.00×0.07×0.02×
Interest Coverage72.67×89.28×◆ 455.22×20.55×188.35× -61%
Scale — latest FY
Revenue / Total Income₹6,929 Cr₹2,520 Cr₹3,822 Cr₹9,646 Cr₹5,329 Cr +30%
Net Income₹1,552 Cr₹722 Cr₹1,036 Cr₹1,184 Cr₹981 Cr +58%
Total Assets₹6,502 Cr₹4,922 Cr₹4,324 Cr₹12,370 Cr₹7,205 Cr -10%
EPS——₹54.52₹44.98₹49.75
Book Value per Share——₹133.84₹317.85₹225.85
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.